NATIONAL
BUREAU OF ECONOMIC RESEARCH
Location
of Biopharmaceutical Activity Pre-Conference
Iain
Cockburn and Matthew Slaughter, Organizers
July
20, 2007
NBER
PRELIMINARY
PROGRAM
FRIDAY, JULY 20:
8:45 am Coffee and
Pastries
9:15 am Introduction:
IAIN
COCKBURN,
MATTHEW
SLAUGHTER,
9:30 am PIERRE AZOULAY, MIT and NBER
ARIEL
FISHMAN,
Doctors, Dollars and
Drug Development: The Effect of Managed Care on the Clinical Trials Industry
10:00 am ERNST
BERNDT, MIT and NBER
FABIO
THIERS, MIT
Factors
Affecting the Changing Global Location of Clinical Trials: A Survey
10:30 am Beak
10:45 am MARIE
THURSBY, Georgia Institute of Technology and NBER
JERRY
THURSBY,
International
R&D Location Decisions of Biopharma Firms: Survey Evidence
11:15 am KIRA
FABRIZIO and L.G. THOMAS,
Tacit Demand and Innovation in Pharmaceuticals
11:45 am NICK
ARGYRES,
JEFF
FURMAN,
Post-Merger
R&D Re-Organization in The Global Pharmaceutical Industry
12:15 pm Lunch
1:15 pm JUAN ALCACER,
JOHN
CANTWELL and MICHELLE GITTELMAN,
An
Analysis of the Geography of Drug Development and Clinical Trials
1:45 pm ASHISH ARORA,
LEE
BRANSTETTER,
2:15 pm KELLEY PORTER,
KJERSTEN
BUNKER WHITTINGTON,
JASON
OWEN-SMITH,
WALTER
W. POWELL,
Which
Secrets Need to Be in the Air?: An
Analysis of the Geographic Division of
Labor in the Biopharmaceutical Industry
2:45 pm Break
3:00 pm MERCEDES DELGADO-GARCIA,
MARGARET
KYLE,
ANITA
MCGAHAN,
How
Liberalized International Trade Regulations Change the Location of Pharmaceutical
Activities around the World
3:30 pm MEGAN MACGARVIE,
PAMINA KOENIG, Université Paris X
Domestic Regulatory Policy
and the International Location of Pharmaceutical Manufacturing
4:00 pm Adjourn
5/22/07